However, strong CD47 expression was frequently identified in patient groups with non-clear cell RCC subtypes, higher Fuhrman nuclear grades, lymph node metastasis, and advanced stages [37]. Here, CD47 is linked to metastatic malignant neoplasm in the lymph nodes.